Arie Mayer serves as Executive at ORAMED PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, Arie Mayer has executed 9 insider transactions totaling $96.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 4, 2024 involved receiving (via award) 30,000 shares valued at $0.
Arie Mayer currently holds 86,809 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arie Mayer has been a net seller of ORMP stock. They have purchased $19.5K and sold $76.8K worth of shares.
Arie Mayer's most recent insider trade was on Jan 4, 2024, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 17, 2023 | ORMP | $0 | Award | 30,000 | $N/A | Discretionary |
| Apr 4, 2023 | ORMP | $8.4K | Purchase | 3,800 | $2.21 | Discretionary |
| Apr 3, 2023 | ORMP | $11.1K | Purchase | 5,009 | $2.22 | Discretionary |
| Jul 28, 2022 | ORMP | $0 | Award | 12,000 | $N/A | Discretionary |
| Jan 3, 2022 | ORMP | $0 | Award | 6,000 | $N/A | Discretionary |
| Jan 3, 2022 | ORMP | $0 | Award | 6,000 | $N/A | Discretionary |
| Nov 1, 2021 | ORMP | $76.8K | Sale | 3,000 | $25.60 | Discretionary |